Public Congress trade

As of June 10 at 7:31 PM EDT

Sell disclosure

Gilbert Cisneros sold ARQT.

Wells Fargo Advisors Arcutis Biotherapeutics, Inc. - Common stock

Amount

$50,001 to $100,000

Trade date

Mar 20, 2026

Filed

Date not disclosed

Price move

+11.1% since disclosed

ARQT moved from $23 on Jun 9, 2026 to $26 on Jul 3, 2026.

Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.